These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28815607)

  • 1. A 3D tri-culture system reveals that activin receptor-like kinase 5 and connective tissue growth factor drive human glomerulosclerosis.
    Waters JP; Richards YC; Skepper JN; Southwood M; Upton PD; Morrell NW; Pober JS; Bradley JR
    J Pathol; 2017 Nov; 243(3):390-400. PubMed ID: 28815607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
    Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
    Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
    Tan Y; Wang B; Keum JS; Jaffa AA
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
    Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
    J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFβ receptor I transactivation mediates stretch-induced Pak1 activation and CTGF upregulation in mesangial cells.
    Chen G; Chen X; Sukumar A; Gao B; Curley J; Schnaper HW; Ingram AJ; Krepinsky JC
    J Cell Sci; 2013 Aug; 126(Pt 16):3697-712. PubMed ID: 23781022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
    Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
    Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
    Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
    Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
    Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine role for TGF-β-induced CTGF and VEGF in mesangial matrix expansion in progressive glomerular disease.
    Lee HS
    Histol Histopathol; 2012 Sep; 27(9):1131-41. PubMed ID: 22806900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of connective tissue growth factor and of TGF-beta isoforms during glomerular injury recapitulate glomerulogenesis.
    Ito Y; Goldschmeding R; Kasuga H; Claessen N; Nakayama M; Yuzawa Y; Sawai A; Matsuo S; Weening JJ; Aten J
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F545-58. PubMed ID: 20576680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes from high glucose-treated glomerular endothelial cells trigger the epithelial-mesenchymal transition and dysfunction of podocytes.
    Wu X; Gao Y; Xu L; Dang W; Yan H; Zou D; Zhu Z; Luo L; Tian N; Wang X; Tong Y; Han Z
    Sci Rep; 2017 Aug; 7(1):9371. PubMed ID: 28839221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-21 in glomerular injury.
    Lai JY; Luo J; O'Connor C; Jing X; Nair V; Ju W; Randolph A; Ben-Dov IZ; Matar RN; Briskin D; Zavadil J; Nelson RG; Tuschl T; Brosius FC; Kretzler M; Bitzer M
    J Am Soc Nephrol; 2015 Apr; 26(4):805-16. PubMed ID: 25145934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
    Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
    J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical tension increases CCN2/CTGF expression and proliferation in gingival fibroblasts via a TGFβ-dependent mechanism.
    Guo F; Carter DE; Leask A
    PLoS One; 2011; 6(5):e19756. PubMed ID: 21611193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic role of TGF-β in the progression of podocyte diseases.
    Lee HS
    Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential role of mesangial cells and podocytes in TGF-beta-induced mesangial matrix synthesis in chronic glomerular disease.
    Lee HS; Song CY
    Histol Histopathol; 2009 Jul; 24(7):901-8. PubMed ID: 19475536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
    Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
    Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFβ type II receptor with implications for nephropathic cell phenotypes.
    Faherty N; Curran SP; O'Donovan H; Martin F; Godson C; Brazil DP; Crean JK
    J Cell Sci; 2012 Dec; 125(Pt 23):5621-9. PubMed ID: 22976296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA-targeting transforming growth factor-β type I receptor reduces wound scarring and extracellular matrix deposition of scar tissue.
    Wang YW; Liou NH; Cherng JH; Chang SJ; Ma KH; Fu E; Liu JC; Dai NT
    J Invest Dermatol; 2014 Jul; 134(7):2016-2025. PubMed ID: 24670383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.